Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Naive and Previously Infected Healthcare Workers

被引:2
|
作者
Algarate, Sonia [1 ,2 ,3 ]
Serrano, Laura [1 ,3 ]
Bueno, Jessica [1 ,2 ]
Herrero-Cortina, Beatriz [1 ,3 ,4 ]
Alvarado, Elena [1 ]
Gonzalez-Barriga, Maria T. [1 ,3 ]
Ducons, Maria [1 ]
Montero-Marco, Jesica [1 ,3 ]
Arnal, Sara [1 ]
Acha, Beatriz [1 ,3 ]
Riesgo, Maria [1 ]
Taboada, Ana [1 ,3 ]
Sanz-Burillo, Pilar [1 ,3 ]
Yuste, Cristina [1 ,3 ]
Benito, Rafael [1 ,2 ,3 ]
机构
[1] Hosp Clin Univ Lozano Blesa Zaragoza, Ave San Juan Bosco 15, Zaragoza 50009, Spain
[2] Univ Zaragoza, Microbiol Dept, Calle Pedro Cerbuna 12, Zaragoza 50009, Spain
[3] Inst Invest Sanitaria Aragon, Ave San Juan Bosco 13, Zaragoza 50009, Spain
[4] Univ San Jorge, Nursing Dept, Autovia Mudejar,Km 299, Zaragoza 50830, Spain
关键词
SARS-CoV-2; booster vaccine; post-vaccine IgG antibody persistence;
D O I
10.3390/ijms241310713
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our aim was to evaluate the immune response of healthcare workers included in the RIPOVAC study, after receiving a booster dose (third dose), in terms of intensity and persistence of induced antibodies. In the second phase of the RIPOVAC study, between December 2021 and January 2022, eight months after the second dose, 389 voluntary, immunocompetent, non-pregnant healthcare workers received a booster dose of SARS-CoV-2 vaccine, and a serum sample was obtained. Two groups of patients were established: with and without previous SARS-CoV-2 infection. In order to quantify anti-S1 IgG (AU/mL) we used CMIA (Abbott). All of the health workers were anti-S IgG positive 8 months after receiving the booster dose of the vaccine, with a mean of 17,040 AU/mL. In 53 patients without previous infection, antibody levels increased by a mean of 10,762 AU/mL. This figure is seven times higher than the one produced after the second dose (1506 AU/mL). The booster dose produces a robust elevation of the antibody level, which persists at 8 months, with levels significantly higher than those reached after the second dose, which allow one to predict a persistence of more than one year. The study demonstrates the efficacy of the booster dose of anti-SARS-CoV-2 vaccines.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers-Orchestra Project
    Violan, Concepcion
    Carrasco-Ribelles, Lucia A.
    Collatuzzo, Giulia
    Ditano, Giorgia
    Abedini, Mahsa
    Janke, Christian
    Reinkemeyer, Christina
    Giang, Le Thi Thu
    Liviero, Filippo
    Scapellato, Maria Luisa
    Mauro, Marcella
    Rui, Francesca
    Porru, Stefano
    Spiteri, Gianluca
    Monaco, Maria Grazia Lourdes
    Carta, Angela
    Otelea, Marina
    Rascu, Agripina
    Fabianova, Eleonora
    Kloslova, Zuzana
    Boffetta, Paolo
    Toran-Monserrat, Pere
    VACCINES, 2023, 11 (08)
  • [32] Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
    Stéphane Marot
    Isabelle Malet
    Valentin Leducq
    Karen Zafilaza
    Delphine Sterlin
    Delphine Planas
    Adélie Gothland
    Aude Jary
    Karim Dorgham
    Timothée Bruel
    Sonia Burrel
    David Boutolleau
    Olivier Schwartz
    Guy Gorochov
    Vincent Calvez
    Anne-Geneviève Marcelin
    Nature Communications, 12
  • [33] Kinetics of Humoral Immunity against SARS-CoV-2 in Healthcare Workers after the Third Dose of BNT162b2 mRNA Vaccine
    Grassi, Tiziana
    Lobreglio, Giambattista
    Panico, Alessandra
    Rosato, Chiara
    Zizza, Antonella
    Lazzari, Roberta
    Chicone, Michele
    Indino, Floriano
    Bagordo, Francesco
    VACCINES, 2022, 10 (11)
  • [34] A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study
    Serra, Nicola
    Andriolo, Maria
    Butera, Ignazio
    Mazzola, Giovanni
    Sergi, Consolato Maria
    Fasciana, Teresa Maria Assunta
    Giammanco, Anna
    Gagliano, Maria Chiara
    Cascio, Antonio
    Di Carlo, Paola
    VACCINES, 2023, 11 (07)
  • [35] Rapid decay of anti-SARS-CoV-2 antibodies in infection-naive healthcare workers four months after vaccination
    Stamatopoulou, Maria
    Tsamadias, Vasileios
    Theodosopoulos, Theodosios
    Demeridou, Stiliani
    Kaparos, George
    Memos, Nikolaos
    Konstadoulakis, Manoussos
    Baka, Stavroula
    GERMS, 2021, 11 (04): : 625 - 629
  • [36] SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
    Narowski, Tara M.
    Raphel, Kristin
    Adams, Lily E.
    Huang, Jenny
    Vielot, Nadja A.
    Jadi, Ramesh
    de Silva, Aravinda M.
    Baric, Ralph S.
    Lafleur, John E.
    Premkumar, Lakshmanane
    CELL REPORTS, 2022, 38 (05):
  • [37] Antibody Response after 3-Dose Booster against SARS-CoV-2 mRNA Vaccine in Kidney Transplant Recipients
    Tripodi, Domenico
    Dominici, Roberto
    Sacco, Davide
    Santorelli, Gennaro
    Rivera, Rodolfo
    Acquaviva, Sandro
    Marchisio, Marino
    Brambilla, Paolo
    Battini, Graziana
    Leoni, Valerio
    VACCINES, 2024, 12 (03)
  • [38] Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
    Yoon, Sarang K.
    Hegmann, Kurt T.
    Thiese, Matthew S.
    Burgess, Jefferey L.
    Ellingson, Katherine
    Lutrick, Karen
    Olsho, Lauren E. W.
    Edwards, Laura J.
    Sokol, Brian
    Caban-Martinez, Alberto J.
    Schaefer-Solle, Natasha
    Jones, John M.
    Tyner, Harmony
    Hunt, Angela
    Respet, Karley
    Gaglani, Manjusha
    Dunnigan, Kayan
    Rose, Spencer
    Naleway, Allison
    Groom, Holly
    Kuntz, Jennifer
    Fowlkes, Ashley L.
    Thompson, Mark G.
    Yoo, Young M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (19): : 1855 - 1857
  • [39] SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months
    Colm Kerr
    Niamh Allen
    Gerry Hughes
    Martina Kelly
    Fiona O’Rourke
    Yvonne Lynagh
    Jean Dunne
    Brendan Crowley
    Niall Conlon
    Colm Bergin
    Irish Journal of Medical Science (1971 -), 2022, 191 : 1089 - 1092
  • [40] SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months
    Kerr, Colm
    Allen, Niamh
    Hughes, Gerry
    Kelly, Martina
    O'Rourke, Fiona
    Lynagh, Yvonne
    Dunne, Jean
    Crowley, Brendan
    Conlon, Niall
    Bergin, Colm
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (03) : 1089 - 1092